Cyclosporine-a attenuates retinal inflammation by inhibiting HMGB-1 formation in rats with type 2 diabetes mellitus

Cyclosporine-A has been regarded as an immunoregulatory and anti-inflammatory drug for the treatment of various immune inflammatory diseases. However, the effect of Cyclosporine-A on the retina of type 2 diabe...

Source: BMC Clinical Pharmacology - February 4, 2020 Category: Drugs & Pharmacology Authors: Peng Wang, Fei Chen and Xuedong Zhang Tags: Research article Source Type: research